Dabucon, Nereka M.

HRN: 25-35-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2025
CEFTAZIDIME 1GM (VIAL)
01/10/2025
01/17/2025
IV
2g
OD
Acute Pulmonary Congestion Sec To CKD
Waiting Final Action 
01/10/2025
AZITHROMYCIN 500MG TABLET (TAB)
01/10/2025
01/14/2025
PO
500mg
OD
Acute Pulmonary Congestion Sec To CKD
Waiting Final Action 
01/16/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
01/16/2025
01/16/2025
IV
80mg
Once
IJ Catheter Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: